Shanmuga Hospital Limited Announces Strategic Growth and Commitment to Quality Healthcare

Salem (Tamil Nadu) [India], February 11:  Shanmuga Hospital Limited, a leading multispecialty healthcare provider in Salem, proudly reaffirms its commitment to providing high-quality medical care as it embarks on its next phase of growth. With 151 beds and state-of-the-art medical facilities, the hospital continues to enhance its services to meet the growing healthcare needs of the region.

As a NABH and NABL-accredited institution, Shanmuga Hospital is dedicated to excellence in patient care, offering specialized treatments in oncology, neurology, cardiology, and more. The hospital is also empaneled with various government agencies and insurance providers, ensuring accessible and affordable treatment for a wider community.

Speaking on the occasion, Dr. Panneerselvam Palaniappan Shanmugam, Managing Director, Shanmuga Hospital Limited, said:

“Our journey has always been about putting patients first. With advanced medical technologies and a dedicated team of professionals, we strive to set new benchmarks in healthcare. This expansion aligns with our vision to provide comprehensive, affordable, and quality medical services. We remain committed to innovation, efficiency, and enhancing patient experiences.”

The hospital recently announced its upcoming Initial Public Offering (IPO), opening on February 13, 2025, and closing on February 17, 2025, on the BSE SME platform. The IPO aims to support capital expenditure for acquiring cutting-edge medical equipment and strengthening the hospital’s infrastructure.

With a strong legacy in healthcare and a patient-centric approach, Shanmuga Hospital Limited is poised for continued success, reinforcing its role as a trusted healthcare partner in Tamil Nadu.

For media inquiries, please contact:

Vikrm B Sanass

Director

ICon PR and Media

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

Related Posts

Maximus International Closes FY26 with 18% Revenue Growth and Record Q4 Performance

New Delhi [India], June 4: Maximus International Limited (BSE: 540401), a premier manufacturer and distributor of specialty lubricants and petroleum products, announced its Board-approved audited financial results for the quarter and financial year ended 31st March…

TransBnk Rebrands to TBX; Expands its Vision for the Future of Corporate Banking

New Delhi [India], June 4: TransBnk, India’s leading tech-first corporate banking and financial infrastructure platform, today unveiled its strategic rebranding to TBX, underscoring the company’s evolution from a transaction banking…

You Missed

Dr. Shankar Ghanshamdas Andani Creates Literary History with 106 Self-Authored Books Published in a Single Day, Earns Multiple World Record Recognitions

  • By
  • June 4, 2026
Dr. Shankar Ghanshamdas Andani Creates Literary History with 106 Self-Authored Books Published in a Single Day, Earns Multiple World Record Recognitions

Pune Cardiologist Dr. Ranjit Jagtap Notes Rise in Heart Cases

  • By
  • June 4, 2026
Pune Cardiologist Dr. Ranjit Jagtap Notes Rise in Heart Cases

Have We Been Chanting Mantras Without Truly Understanding Them? Mehul Vora’s Decoding Mantras Re-examines Modern Spiritual Understanding

  • By
  • June 4, 2026
Have We Been Chanting Mantras Without Truly Understanding Them? Mehul Vora’s Decoding Mantras Re-examines Modern Spiritual Understanding

CRICKETER OF THE CENTURY: A Prediction Before the World Took Notice

  • By
  • June 4, 2026
CRICKETER OF THE CENTURY: A Prediction Before the World Took Notice

20,000+ Doctors and continuing – How Medisage AI Spread Through India’s Medical Community

  • By
  • June 4, 2026
20,000+ Doctors and continuing – How Medisage AI Spread Through India’s Medical Community

FUME Reaches 15,000 Clients Across India and Abroad, Establishing India’s Leading Diagnostic-First Root-Cause Metabolic Decoding Platform

  • By
  • June 4, 2026
FUME Reaches 15,000 Clients Across India and Abroad, Establishing India’s Leading Diagnostic-First Root-Cause Metabolic Decoding Platform